Functional analysis of in-frame indel ARID1A mutations reveals new regulatory mechanisms of its tumor suppressor functions

Neoplasia (United States)

Volumn 14, Issue 10, 2012, Pages 986-993

  Guan, Bin ^a   Gao, Min ^a   Wu, Chen Hsuan ^a   Wang, Tian Li ^a   Shih, Ie Ming ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AT RICH INTERACTIVE DOMAIN 1A; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; LEPTOMYCIN B; PROTEIN P21; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CELL FRACTIONATION; CELL PROLIFERATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; FLOW CYTOMETRY; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LUNG CANCER; NUCLEAR EXPORT SIGNAL; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STABILITY; STOMACH CARCINOMA; TRANSCRIPTION REGULATION; UBIQUITINATION; WESTERN BLOTTING;

EID: 84867796875     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.121218     Document Type: Article

References (22)

1. Jones S, Wang TL, Shih Ie M, Mao TL, Nakayama K, Roden R, Glas R, Slamon D, Diaz LA Jr, Vogelstein B, et al. (2010). Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 330, 228-231.
2. Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng T, Senz J, McConechy MK, Anglesio MS, Kalloger SE, et al. (2010). ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 363, 1532-1543.
3. Guan B, Mao TL, Panuganti PK, Kuhn E, Kurman RJ, Maeda D, Chen E, Jeng YM, Wang TL, and Shih Ie M (2011). Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma. Am J Surg Pathol 35, 625-632.
4. Jones S, Li M, Parsons DW, Zhang X, Wesseling J, Kristel P, Schmidt MK, Markowitz S, Yan H, Bigner D, et al. (2012). Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types. Hum Mutat 33, 100-103.
5. Gui Y, Guo G, Huang Y, Hu X, Tang A, Gao S, Wu R, Chen C, Li X, Zhou L, et al. (2011). Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet 43, 875-878.
6. Wang K, Kan J, Yuen ST, Shi ST, Chu KM, Law S, Chan TL, Kan Z, Chan AS, Tsui WY, et al. (2011). Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat Genet 43, 1219-1223.
7. Guan B, Wang TL, and Shih Ie M (2011). ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. Cancer Res 71, 6718-6727.
8. Treier M, Staszewski LM, and Bohmann D (1994). Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78, 787-798.
9. Nitta M, Katabuchi H, Ohtake H, Tashiro H, Yamaizumi M, and Okamura H (2001). Characterization and tumorigenicity of human ovarian surface epithelial cells immortalized by SV40 large T antigen. Gynecol Oncol 81, 10-17.
10. Gorai I, Nakazawa T, Miyagi E, Hirahara F, Nagashima Y, and Minaguchi H (1995). Establishment and characterization of two human ovarian clear cell adenocarcinoma lines from metastatic lesions with different properties. Gynecol Oncol 57, 33-46.
11. Sastry L, Johnson T, Hobson MJ, Smucker B, and Cornetta K (2002). Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods. Gene Ther 9, 1155-1162.
12. Guan B, Pungaliya P, Li X, Uquillas C, Mutton LN, Rubin EH, and Bieberich CJ (2008). Ubiquitination by TOPORS regulates the prostate tumor suppressor NKX3.1. J Biol Chem 283, 4834-4840.
13. Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad IB, Calderaro J, Bioulac-Sage P, Letexier M, Degos F, et al. (2012). Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet 44, 694-698.
14. Fujimoto A, Totoki Y, Abe T, Boroevich KA, Hosoda F, Nguyen HH, Aoki M, Hosono N, Kubo M, Miya F, et al. (2012). Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet 44, 760-764.
15. Nagl NG Jr, Patsialou A, Haines DS, Dallas PB, Beck GR Jr, and Moran E (2005). The p270 (ARID1A/SMARCF1) subunit of mammalian SWI/SNF-related complexes is essential for normal cell cycle arrest. Cancer Res 65, 9236-9244.
16. Ossareh-Nazari B, Bachelerie F, and Dargemont C (1997). Evidence for a role of CRM1 in signal-mediated nuclear protein export. Science 278, 141-144.
17. Dingwall C, Sharnick SV, and Laskey RA (1982). A polypeptide domain that specifies migration of nucleoplasmin into the nucleus. Cell 30, 449-458.
18. von Mikecz A (2006). The nuclear ubiquitin-proteasome system. J Cell Sci 119, 1977-1984.
19. Muratani M and Tansey WP (2003). How the ubiquitin-proteasome system controls transcription. Nat Rev Mol Cell Biol 4, 192-201.
20. Kinyamu HK, Chen J, and Archer TK (2005). Linking the ubiquitin-proteasome pathway to chromatin remodeling/modification by nuclear receptors. J Mol Endocrinol 34, 281-297.
21. Lipford JR, Smith GT, Chi Y, and Deshaies RJ (2005). A putative stimulatory role for activator turnover in gene expression. Nature 438, 113-116.
22. Li XS, Trojer P, Matsumura T, Treisman JE, and Tanese N (2010). Mammalian SWI/SNF-a subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B. Mol Cell Biol 30, 1673-1688.